Dannielle Appelhans, CEO and President at Rubius Therapeutics, Inc. (RUBY), sold 10,385 shares at $0.13 ($1K) on 2023-02-24, disclosed to the SEC on 2023-02-27.
Open-market sale of $1k RUBY by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RUBY | SELL | 2023-02-01 | $970 | — | Filing → |
| RUBY | SELL | 2022-08-12 | $5K | — | Filing → |